Un grazie a Radio 24 per l’invito a Il Cowboy e lo Stivale. Stimolante il confronto con Giuseppe Remuzzi e Andrew Spannaus su sanità, obesità e diabete: come abitudini, ambiente e politiche sanitarie plasmano la nostra salute. www.radio24.ilsole24ore.com/programmi/Il... #Diabete #Obesità #Radio24

🧬 New case report in Acta Diabetologica: 10-year follow-up of islet transplantation in a patient with Wolfram syndrome. Non-autoimmune, insulinopenic diabetes — still responsive to beta-cell replacement. Rethinking eligibility. 🔗 doi.org/10.1007/s005... #Diabetes #IsletTx

“Pole pole” — I learned it climbing Kilimanjaro: slow, steady, with respect. Now it’s the spirit of our new @AmJTransplant commentary on cautiously exploring IAT in IPMN patients. Science moves best when it listens. 👉 doi.org/10.1016/j.aj... #IAT #IPMN #PolePole

How should we assess graft function after islet autotransplantation? A study from @SanRaffaeleMI compares 6 outcome classification systems—including a data-driven model that better captures intermediate outcomes. www.frontierspartnerships.org/journals/tra...

Can β-cell replacement therapies for type 1 diabetes move beyond being a last resort? In this new Diabetes article, we explore what’s possible, what’s needed, and what questions remain. 📄 doi.org/10.2337/dbi2... #T1D #BetaCell #DiabetesResearch

#ESPEESE2025 has just wrapped up in Copenhagen! We joined the Meet the Expert session on #Type1Diabetes therapies as guests from the DRI @SanRaffaeleMI. The real challenge? Endocrine care that follows the patient across their whole life. Easy to say… hard to do… but not impossible. #SanRaffaeleMI

We’re excited to share our latest work published in the American Journal of Transplantation: Islet Autotransplantation in Focal Intraductal Papillary Mucinous Neoplasms: Evaluating Feasibility, Safety, and Metabolic Outcomes in Pancreatic Resection kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F...

April 11, 2025 – National Day for Organ Donation and Transplantation. The breath becomes silence, but it doesn’t end. Time just changes its body. #OrganDonation #DonateLife #April11 www.facebook.com/share/v/1HSJ...

We’ve been exploring the potential of GLP-1 receptor agonists for treating Wolfram Syndrome, a rare form of diabetes. #WolframSyndrome #GLP1 diabetesjournals.org/diabetes/art...

Just published www.frontierspartnerships.org/journals/tra...

Bringing new therapy to patients needs strong clinical trials and regulatory alignment. Europe is updating GCP guidelines (ICH E6(R3)) to boost efficiency while ensuring safety and transparency 💡 Why does it matter? To deliver innovative therapies faster. #CellTherapies #Diabetes #GCP #ACTEUworkshop

A long story about our activity just published Long-term outcomes of pancreatic islet transplantation alone in type 1 diabetes: a 20-year single-centre study in Italy - The Lancet Diabetes & Endocrinology www.thelancet.com/journals/lan...